ACUTE MYELOID LEUKEMIA WITH FLT3/ITD MUTATION

Clinical trials for ACUTE MYELOID LEUKEMIA WITH FLT3/ITD MUTATION explained in plain language.

Never miss a new study

Get alerted when new ACUTE MYELOID LEUKEMIA WITH FLT3/ITD MUTATION trials appear

Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA WITH FLT3/ITD MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Completed 1

Gentler transplant strategy tested for tough blood cancers

Disease control Completed

This study tested a two-step, lower-intensity stem cell transplant for patients with high-risk blood cancers like leukemia and lymphoma. The goal was to use milder chemotherapy and radiation before the transplant to reduce side effects while still allowing the donor's immune cell…

Matched conditions: ACUTE MYELOID LEUKEMIA WITH FLT3/ITD MUTATION

Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control

Last updated Mar 02, 2026 15:26 UTC

ACUTE MYELOID LEUKEMIA WITH FLT3/ITD MUTATION

Get alerted when new ACUTE MYELOID LEUKEMIA WITH FLT3/ITD MUTATION trials appear

Gentler transplant strategy tested for tough blood cancers